Suppr超能文献

家族性扩张型心肌病研究项目中的基因检测结果反馈

Return of genetic results in the familial dilated cardiomyopathy research project.

作者信息

Siegfried Jill D, Morales Ana, Kushner Jessica D, Burkett Emily, Cowan Jason, Mauro Ana Clara, Huggins Gordon S, Li Duanxiang, Norton Nadine, Hershberger Ray E

机构信息

Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

J Genet Couns. 2013 Apr;22(2):164-74. doi: 10.1007/s10897-012-9532-8. Epub 2012 Aug 11.

Abstract

The goal of the Familial Dilated Cardiomyopathy (FDC) Research Project, initiated in 1993, has been to identify and characterize FDC genetic cause. All participating individuals have been consented for the return of genetic results, an important but challenging undertaking. Since the inception of the Project we have enrolled 606 probands, and 269 of these had 1670 family members also enrolled. Each subject was evaluated for idiopathic dilated cardiomyopathy (IDC) and pedigrees were categorized as familial or sporadic. The coding regions of 14 genes were resequenced in 311 to 324 probands in five studies. Ninety-two probands were found to carry nonsynonymous rare variants absent in controls, and with Clinical Laboratory Improvement Amendment of 1988 (CLIA) compliant protocols, relevant genetic results were returned to these probands and their consented relatives by study genetic counselors and physicians in 353 letters. In 10 of the 51 families that received results >1 year ago, at least 23 individuals underwent CLIA confirmation testing for their family's rare variant. Return of genetic results has been successfully undertaken in the FDC Research Project. This report describes the methods utilized in the process of returning research results. We use this information as a springboard for providing guidance to other genetic research groups and proposing future directions in this arena.

摘要

始于1993年的家族性扩张型心肌病(FDC)研究项目的目标,是识别并描述FDC的遗传病因。所有参与研究的个体均已同意接收遗传检测结果,这是一项重要但具有挑战性的工作。自该项目启动以来,我们已招募了606名先证者,其中269名先证者的1670名家庭成员也参与了研究。对每个受试者进行特发性扩张型心肌病(IDC)评估,并将家系分类为家族性或散发性。在五项研究中,对311至324名先证者的14个基因的编码区进行了重测序。发现92名先证者携带对照中不存在的非同义罕见变异,并且按照符合1988年《临床实验室改进修正案》(CLIA)的方案,研究遗传咨询师和医生通过353封信函,将相关遗传结果告知了这些先证者及其同意接收结果的亲属。在一年多前收到结果的51个家庭中的10个家庭中,至少有23名个体针对其家族的罕见变异进行了CLIA确认检测。FDC研究项目已成功完成了遗传结果的反馈工作。本报告描述了在反馈研究结果过程中所采用的方法。我们以此信息为契机,为其他基因研究团队提供指导,并提出该领域未来的发展方向。

相似文献

1
Return of genetic results in the familial dilated cardiomyopathy research project.
J Genet Couns. 2013 Apr;22(2):164-74. doi: 10.1007/s10897-012-9532-8. Epub 2012 Aug 11.
2
Clinical and genetic issues in familial dilated cardiomyopathy.
J Am Coll Cardiol. 2005 Apr 5;45(7):969-81. doi: 10.1016/j.jacc.2004.11.066.
3
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.
Am Heart J. 2008 Jul;156(1):161-9. doi: 10.1016/j.ahj.2008.01.026. Epub 2008 Mar 12.
5
Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy.
J Card Fail. 2006 Aug;12(6):422-9. doi: 10.1016/j.cardfail.2006.03.009.
7
Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.
J Am Coll Cardiol. 2011 Apr 19;57(16):1641-9. doi: 10.1016/j.jacc.2011.01.015.
8
Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.
Genet Med. 2010 Nov;12(11):655-67. doi: 10.1097/GIM.0b013e3181f2481f.
10
Periodic rescreening is indicated for family members at risk of developing familial dilated cardiomyopathy.
J Am Coll Cardiol. 2002 May 1;39(9):1503-7. doi: 10.1016/s0735-1097(02)01788-6.

引用本文的文献

3
Titin mutations and muscle disease.
Pflugers Arch. 2019 May;471(5):673-682. doi: 10.1007/s00424-019-02272-5. Epub 2019 Mar 27.
4
Genetics of Dilated Cardiomyopathy: Clinical Implications.
Curr Cardiol Rep. 2018 Aug 13;20(10):83. doi: 10.1007/s11886-018-1030-7.
7
Clinical verification of genetic results returned to research participants: findings from a Colon Cancer Family Registry.
Mol Genet Genomic Med. 2017 Nov;5(6):700-708. doi: 10.1002/mgg3.328. Epub 2017 Aug 23.
10
Research participant-centered outcomes at NIH-supported clinical research centers.
Clin Transl Sci. 2014 Dec;7(6):430-40. doi: 10.1111/cts.12167. Epub 2014 May 19.

本文引用的文献

1
Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.
J Genet Couns. 2001 Oct;10(5):397-415. doi: 10.1023/A:1016641504606.
2
Researchers' opinions towards the communication of results of biobank research: a survey study.
Eur J Hum Genet. 2012 Mar;20(3):258-62. doi: 10.1038/ejhg.2011.216. Epub 2011 Nov 30.
3
Secrets of the human genome disclosed.
Nature. 2011 Oct 4;478(7367):17. doi: 10.1038/478017a.
5
Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.
Am J Hum Genet. 2011 Jul 15;89(1):28-43. doi: 10.1016/j.ajhg.2011.05.017. Epub 2011 Jun 23.
6
Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.
J Am Coll Cardiol. 2011 Apr 19;57(16):1641-9. doi: 10.1016/j.jacc.2011.01.015.
8
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.
Am J Hum Genet. 2011 Mar 11;88(3):273-82. doi: 10.1016/j.ajhg.2011.01.016. Epub 2011 Feb 25.
9
Research ethics. Research practice and participant preferences: the growing gulf.
Science. 2011 Jan 21;331(6015):287-8. doi: 10.1126/science.1199000.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验